Synopsis
Synopsis
0
EU WC
0
KDMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dextran
2. Dextran 40000
3. Dextran 70
4. Dextran 75
5. Dextran 80
6. Dextran B 1355
7. Dextran B 1355 S
8. Dextran B-1355
9. Dextran B-1355-s
10. Dextran B1355
11. Dextran B512
12. Dextran Derivatives
13. Dextran M 70
14. Dextran T 40
15. Dextran T 500
16. Dextran T 70
17. Dextran T-40
18. Dextran T-500
19. Dextrans
20. Hemodex
21. Hyskon
22. Infukoll
23. Macrodex
24. Polyglucin
25. Promit
26. Rheodextran
27. Rheoisodex
28. Rheomacrodex
29. Rheopolyglucin
30. Rondex
31. Saviosol
1. L3l3xyp7mp
2. Lmwd
3. Schembl206877
4. Chembl1697742
5. O-alpha-d-glucopyranosyl-(1.6)-o-alpha-d-glucopyranosyl-(1.6)-d-glucose
6. Hy-n0913a
7. Dtxsid701317190
8. 6-.alpha.-isomaltosylglucose
9. Zinc64622163
10. Cs-0109495
11. D-glucose, O-.alpha.-d-glucopyranosyl-(1->6)-o-.alpha.-d-glucopyranosyl-(1->6)-
12. O-alpha-d-glucopyranosyl-(1-->6)-o-alpha-d-glucopyranosyl-(1-->6)-d-glucose
13. Wurcs=2.0/2,3,2/[o2122h][a2122h-1a_1-5]/1-2-2/a6-b1_b6-c1
14. (2r,3s,4r,5r)-2,3,4,5-tetrahydroxy-6-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)methyl)oxan-2-yl)oxy)hexanal
Molecular Weight | 504.4 g/mol |
---|---|
Molecular Formula | C18H32O16 |
XLogP3 | -7.2 |
Hydrogen Bond Donor Count | 11 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 11 |
Exact Mass | 504.16903493 g/mol |
Monoisotopic Mass | 504.16903493 g/mol |
Topological Polar Surface Area | 277 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 625 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 14 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Plasma Substitutes
Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration. (See all compounds classified as Plasma Substitutes.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19584
Submission : 2006-06-30
Status : Active
Type : II
Certificate Number : R1-CEP 1999-063 - Rev 03
Issue Date : 2022-01-03
Type : Chemical
Substance Number : 999
Status : Valid
NDC Package Code : 49442-5001
Start Marketing Date : 2011-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : DRUG FOR FURTHER PROCESSING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23092
Submission : 2009-07-31
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1183
Submission : 1968-05-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1184
Submission : 1968-05-07
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 353
Submission : 1959-11-16
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 462
Submission : 1962-01-08
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2573
Submission : 1975-12-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9447
Submission : 1991-12-05
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : R1-CEP 1999-064 - Rev 03
Issue Date : 2022-01-03
Type : Chemical
Substance Number : 1000
Status : Valid
NDC Package Code : 49442-5001
Start Marketing Date : 2011-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : DRUG FOR FURTHER PROCESSING
Certificate Number : R1-CEP 1999-065 - Rev 03
Issue Date : 2022-01-03
Type : Chemical
Substance Number : 1001
Status : Valid
NDC Package Code : 49442-5001
Start Marketing Date : 2011-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : DRUG FOR FURTHER PROCESSING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1183
Submission : 1968-05-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1184
Submission : 1968-05-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19584
Submission : 2006-06-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23092
Submission : 2009-07-31
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 462
Submission : 1962-01-08
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 353
Submission : 1959-11-16
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9447
Submission : 1991-12-05
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2573
Submission : 1975-12-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : R1-CEP 2003-165 - Rev 01
Status : Valid
Issue Date : 2022-01-03
Type : Chemical
Substance Number : 1506
Certificate Number : R1-CEP 1999-065 - Rev 03
Status : Valid
Issue Date : 2022-01-03
Type : Chemical
Substance Number : 1001
Certificate Number : R1-CEP 1999-064 - Rev 03
Status : Valid
Issue Date : 2022-01-03
Type : Chemical
Substance Number : 1000
Certificate Number : R1-CEP 1999-063 - Rev 03
Status : Valid
Issue Date : 2022-01-03
Type : Chemical
Substance Number : 999
Dextran sulfate sodium sulfur-18
Registration Number : 218MF10826
Registrant's Address : 2-41 Sasazukacho, Nishi-ku, Nagoya
Initial Date of Registration : 2006-10-20
Latest Date of Registration : 2006-10-20
Dextran sulfate sodium sulfur 5
Registration Number : 218MF10831
Registrant's Address : 2-41 Sasazukacho, Nishi-ku, Nagoya
Initial Date of Registration : 2006-10-20
Latest Date of Registration : 2006-10-20
Registration Number : 217MF11169
Registrant's Address : 2-41 Sasazukacho, Nishi-ku, Nagoya City, Aichi Prefecture
Initial Date of Registration : 2005-12-12
Latest Date of Registration : 2018-10-01
NDC Package Code : 49442-5040
Start Marketing Date : 2006-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49442-5070
Start Marketing Date : 2011-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 49442-5800
Start Marketing Date : 2015-06-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49442-5060
Start Marketing Date : 2011-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 49442-5001
Start Marketing Date : 2011-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 49442-5600
Start Marketing Date : 2015-07-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
About the Company : PT. Cahaya Mandiri Farma is a leading company in the pharmaceutical industry, dedicated to producing high-quality healthcare products for humans. We are committed to excellence thr...
About the Company : SWATI SPENTOSE PVT. LTD.(SSPL), a pharmaceutical company based in Mumbai, India having 2 manufacturing sites: SSPL Unit 1 and SSPL Unit 2. Please find attached a brief presentation...
About the Company : Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates, GMP & ...
About the Company : Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates, GMP & ...
About the Company : Xi'an Wanlong Pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates, GMP & ...
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?